相关实验视频
Updated: Jun 11, 2025

07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
40
准血清标记物介素9可以改善类风湿性关节炎的基本特征和免疫平衡
Ying Xiong1, Wang Xiang2, Wei Xiao2
1Department of Rheumatology and Immunology, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Central-European journal of immunology
|October 9, 2024
概括
介质蛋白9 (IL-9) 显示出作为血清阴性类风湿性关节炎 (SNRA) 的诊断标记物具有前途. 抑制IL-9通过调节免疫反应和炎症,有效地减少了大鼠模型中的关节炎严重程度.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 生物化学 生物化学
背景情况:
- 类风湿性关节炎 (RA) 诊断通常依赖于类风湿性因素 (RF) 和抗素化抗体 (ACPA).
- 一个被称为血清阴性RA (SNRA) 的RA患者子组缺乏这些传统的血清学标志物.
- 确定SNRA可靠的生物标志物对于准确的诊断和有效的治疗至关重要.
研究的目的:
- 为了研究Interleukin 9 (IL-9) 作为血清阴性类风湿性关节炎 (SNRA) 的诊断标记物的潜力.
- 在临床前模型中评估IL-9抑制对关节炎严重程度和免疫细胞调节的治疗效果.
主要方法:
- 从SNRA患者的血清样本和由原诱导的关节炎 (CIA) 的大鼠模型中分析了IL-9水平.
- 重组性大鼠IL-9 (rrIL-9) 和抗大鼠IL-9中和单克隆抗体 (mAb) 对关节炎严重程度,免疫细胞群 (Treg,Th17,M1/M2巨细胞) 和细胞因子水平的影响在CIA大鼠中进行了评估.
主要成果:
- 与健康对照组相比,在SNRA患者中观察到IL-9水平升高.
- 在CIA大鼠中,IL-9被确定为RA诊断的敏感标记物,与关节炎得分增加和关节损伤相关.
- IL-9加剧了关节炎,而IL-9抑制改善了症状,促进了Treg/Th17平衡,将巨细胞偏向转向M2,并减少了炎症类细胞因子.
结论:
- 介素9 (IL-9) 显示出作为一种新型诊断生物标志物的潜力,用于血清阴性类风湿性关节炎 (SNRA).
- 向IL-9提供了一个有希望的治疗策略,通过调节Treg/Th17和巨细胞反应来减少RA相关的炎症和免疫失调.
相关概念视频
T Cell Types and Functions
959
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
959
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K

